Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II study

OBJECTIVES: To investigate the efficacy and safety of nimotuzumab (NTZ) combined with concurrent chemo-radiotherapy (CCRT) in induction chemotherapy (IC) resistant locally advanced nasopharyngeal carcinoma (LANPC). MATERIALS AND METHODS: A single-arm, open-label phase II clinical trial was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Xiaoshuang, Liu, Peiyao, Zhou, Xin, Ou, Dan, Wang, Xiaoshen, Hu, Chaosu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597793/
https://www.ncbi.nlm.nih.gov/pubmed/37865048
http://dx.doi.org/10.1016/j.tranon.2023.101797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597793/
https://www.ncbi.nlm.nih.gov/pubmed/37865048
http://dx.doi.org/10.1016/j.tranon.2023.101797

Ejemplares similares